I had the pleasure of being invited to attend a Bausch and Lomb drug advisory board meeting in Calgary this week. We reviewed antibiotic medications, anti-inflammatory medications and dry eye syndrome treatment protocols. We also spent the afternoon talking about all the new vitamins and nutraceutical products on the market and their involvement in ocular health and their specific benefits towards age related macular degeneration.

The one thing that emerged from the meeting was the confusion surrounding the vitamin or nutraceutical industry and the information or miss information that is available to the public.

Stay tuned for a number of future articles that will touch on many of these topics over the next few weeks.